Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice
- PMID: 11316761
- DOI: 10.1210/endo.142.5.8165
Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice
Abstract
In cell culture systems insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) can both enhance and inhibit IGF-I action. To investigate the biological role of IGFBP-3 in vivo, transgenic (Tg) mice that constitutively overexpress the human IGFBP-3 complementary DNA (cDNA) driven by the mouse phosphoglycerate kinase I (PGK) and the cytomegalovirus (CMV) promoters were examined. Serum levels of human IGFBP-3 in CMVBP-3 and PGKBP-3 Tg mice were 4.7 and 5.8 microgram/ml, respectively and total IGFBP-3 was increased 4.9- and 7.7-fold compared with that in wild-type (Wt) mice. In PGKBP-3 Tg mice the levels of transgene expression were similar in all tissues. Although CMVBP-3 mice demonstrated similar levels of expression of the transgene as PGKBP-3 mice in most tissues, markedly elevated expression was apparent in the kidney and heart. The transgene-derived IGFBP-3 circulated as a 150-kDa ternary complex, and serum IGF-I levels were elevated 1.9- to 2.8-fold in Tg mice compared with Wt mice. A significant reduction in birth weight of approximately 10% and a modest reduction in litter size were apparent in both Tg strains. Early postnatal growth, as assessed by both body weight and length, was significantly reduced in Tg mice compared with Wt mice. This was more marked in PGKBP-3 than in CMVBP-3 mice, who demonstrated a propensity to adiposity after weaning. The relative organ weights of brain and kidney were reduced in both Tg strains, whereas liver size and epididymal fat were significantly increased in CMVBP-3, but not PGKBP-3, mice. Our data indicate that overexpression of IGFBP-3 is associated with modest intrauterine and postnatal growth retardation despite elevated circulating IGF-I levels.
Similar articles
-
Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice.J Bone Miner Res. 2003 Oct;18(10):1834-41. doi: 10.1359/jbmr.2003.18.10.1834. J Bone Miner Res. 2003. PMID: 14584894
-
Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.Endocrinology. 2006 May;147(5):2112-21. doi: 10.1210/en.2005-1270. Epub 2006 Feb 9. Endocrinology. 2006. PMID: 16469805
-
Overexpression of gly56/gly80/gly81-mutant insulin-like growth factor-binding protein-3 in transgenic mice.Endocrinology. 2005 Mar;146(3):1523-31. doi: 10.1210/en.2004-0905. Epub 2004 Nov 18. Endocrinology. 2005. PMID: 15550509
-
Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice.Prog Growth Factor Res. 1995;6(2-4):425-32. doi: 10.1016/0955-2235(95)00026-7. Prog Growth Factor Res. 1995. PMID: 8817686 Review.
-
Role of interleukin-6 in growth failure: an animal model.Horm Res. 2002;58 Suppl 1:24-7. doi: 10.1159/000064757. Horm Res. 2002. PMID: 12373010 Review.
Cited by
-
Insulin-like Growth Factor 1 (IGF1), IGF Binding Protein-3 (IGFBP3) and Growth Response to Daily Zinc Supplementation: A Randomized Trial in Rural Laotian Children.Nutrients. 2023 May 31;15(11):2590. doi: 10.3390/nu15112590. Nutrients. 2023. PMID: 37299552 Free PMC article. Clinical Trial.
-
IGF1R is a mediator of sex-specific metabolism in mice: Effects of age and high-fat diet.Front Endocrinol (Lausanne). 2022 Oct 20;13:1033208. doi: 10.3389/fendo.2022.1033208. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36353242 Free PMC article.
-
Growth Hormone and IGF1 Actions in Kidney Development and Function.Cells. 2021 Nov 30;10(12):3371. doi: 10.3390/cells10123371. Cells. 2021. PMID: 34943879 Free PMC article. Review.
-
Mice with gene alterations in the GH and IGF family.Pituitary. 2022 Feb;25(1):1-51. doi: 10.1007/s11102-021-01191-y. Epub 2021 Nov 19. Pituitary. 2022. PMID: 34797529 Free PMC article. Review.
-
The Rise of IGFBP4 in People with Obstructive Sleep Apnea and Multilevel Sleep Surgery Recovers Its Basal Levels.Dis Markers. 2021 Oct 4;2021:1219593. doi: 10.1155/2021/1219593. eCollection 2021. Dis Markers. 2021. PMID: 34646401 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous